医原性(足母)内翻的外科治疗

目的探讨医原性躅内翻矫形手术治疗的经验与防治方法。方法1989年7月至2005年5月治疗医原性躅内翻27例（28足），男4例（4足），女23例（24足）；年龄24～62岁，平均51.3岁。采用Hiss手术13例（14足）、myerson手术10例（10足）、跖骨远端截骨术4例（4足）。术前对每个病例进行临床、x线片与CT检查，分析其躅内翻的发病原因。术后对所有病例进行随访，按美国足踝外科协会maryland百分制评分系统，对疼痛、功能、体征进行评分。结果27例（28足）获得随访，随访时间1年～17年2个月，平均5．7年。术前评分平均为52．4（41～57）分，术后平均为89（64～100）分。疗效优13足（46_4％），良11足（39．3％），可4足（14-3％），优良率85．7％。施行Hiss手术者中1例术后13年发生蹿长伸肌腱轻度挛缩，采用myerson手术者术后背伸较术前平均减少9.5°（8°。～12．5°。）。医原性躅内翻的发生原因有5个，其中最常见的是在躅外翻矫形时跖骨头内侧骨赘切除过多，本组有14足（50％），然后依次为内侧关节囊过度重叠紧缩缝合5足（17．9％），矫形时过度纠正IMA4足（14-4％），术后长时期固定3足（10．8％），术后躅趾外展与内收肌力失衡2足（6．9％）。结论躅外翻矫形并发躅内翻最常见的原因是对跖骨头内侧骨赘切除过多。术者在治疗医原性躅内翻时，应根据各个病例的不同情况选择不同的术式进行治疗。采用Hiss、Myerson软组织重建术与Chevron跖骨远端截骨术矫正医原性跨内翻切实可行、疗效可靠。     

致敏供者淋巴细胞输注对受者免疫功能重建及移植物抗宿主病发生率的影响

目的探讨非清髓异基因外周血造血干细胞移植后致敏供者淋巴细胞输注(DLI)对受者免疫重建及移植物抗宿主病(GVHD)发生率的影响。方法以C57BL/6小鼠(H-2b)为受鼠, BALB/c小鼠(H-2d)为供鼠,建立异基因外周血造血干细胞移植模型(实验组),移植当天受者接受60Coγ射线全身照射,移植后第2天腹腔注射环磷酰胺200 mg/kg。以不行造血干细胞移植,仅行γ射线全身照射和环磷酰胺腹腔注射的正常C57BL/6小鼠为对照。实验组存活小鼠在移植后第28天分别接受致敏供鼠淋巴细胞输注(n=8)、未致敏供鼠淋巴细胞输注(n=8),另有6只不输注供鼠淋巴细胞。移植后检测受者异基因嵌合率,观察GVHD的发生情况以及T淋巴细胞亚群变化,并行供受者间以及供受者与第三方小鼠(昆明鼠)间的单向混合淋巴细胞反应。结果实验组受鼠SRY基因均为阳性,嵌合率为(30.881±3.962)%。DLI后,接受未致敏DLI者均出现不同程度的GVHD,死亡3只(7.5%,3/8),而接受致敏DLI者无明显GVHD及死亡者。移植后45 d,接受致敏DLI者的CD8 T淋巴细胞明显高于正常C57BL/6小鼠(P<0.05),而接受未致敏DLI者的CD8 T淋巴细胞与正常对照的差异无统计学意义(P>0.05),至移植后60 d,接受DLI者的T淋巴细胞亚群接近正常(P>0.05);对照组T淋巴细胞亚群持续低于正常对照(P<0.05)。实验组小鼠淋巴细胞对供者淋巴细胞刺激的反应性均下降(P<0.01),以接受致敏DLI者最明显,而对昆明鼠淋巴细胞刺激的反应性维持正常水平。结论造血干细胞移植后输注致敏供者的淋巴细胞能促进受者的免疫功能重建,并可减少GVHD的发生。     

Accessory atrioventricular pathway, supra-, and infrahisian conduction impaired due to mitral annulus calcification

Disorders of conduction occurring simultaneously in both normal and accessory pathways of patients with Wolff-Parkinson-White (WPW) syndrome have only rarely been observed. To our knowledge this is the first report of impaired conduction in both pathways in WPW syndrome due to mitral annulus calcification (MAC). This case of WPW syndrome type A presented the following conduction abnormalities: (1) right bundle-branch block; (2) transient second-degree AV block with prolonged PR interval of the conducted beats; (3) during electrophysiological study, induction of tachycardia, dependent (phase 3) second-degree AV block, and occasionally conduction of two consecutive beats, the second showing an increased H-V interval (from 25 to 60 ms) and left bundle-branch block (LBBB) pattern, due to (4) infrahisian conduction abnormality.     

结节性硬化病的CT诊断

目的:探讨结节性硬化(TS)的病因与诊断标准以及CT诊断、分析思路和鉴别诊断。方法:采用CT平扫和增强扫描方法,对3例患者行头部及肾脏检查。结果:3例中伴室管膜下巨细胞星形细胞瘤1例,伴双肾血管平滑肌脂肪瘤1例,另1例孕妇伴双肾血管平滑肌脂肪瘤破裂出血。结论:CT检查对于TS有其特征性表现,基于本病多器官的组织缺陷和错构瘤为特征的系统性疾病特点,优化扫描方案是提高诊断正确率的关键。     

干部人群血尿酸水平与脑血管病的关系

目的探讨干部人群高尿酸血症的患病情况及其与脑血管病的关系。方法对健康体检的1116名机关干部的血尿酸及脑血管病的患病情况进行分析。结果高尿酸血症的总检出率为30．2％，男性35．6％，女性7．1％，高发于50～80岁；高尿酸血症组脑血管病的发病率明显增高。结论高尿酸血症存在性别年龄差异，干部人群血尿酸水平与脑血管病有密切有关，应当引起人们高度重视。     

Mortality in police and firefighters in New Jersey

A proportionate mortality study of police and firefighters in New Jersey was conducted using the records of a comprehensive retirement system. Three reference populations were used: U.S. general population, New Jersey general population, and police as a reference group for the firefighters. Overall neither group differed from the New Jersey male population in the cause of death. Analyses by latency showed an increase in skin cancer and cirrhosis in firefighters and cirrhosis in police. With increased time from first employment, an inverse association was found between heart disease and time of first exposure. This was reflected in statistically significant increased proportionate mortality rates (PMR) for arteriosclerotic heart disease (ASHD) (ICD 410-414) for both working police (PMR = 1.15) and firefighters (PMR = 1.2). Retired police and firefighters had PMRs of 0.96 and 0.98, respectively. Firefighters had a significant increase in nonmalignant respiratory disease (PMR = 1.98) and leukemia (PMR = 2.76) when the police were used as a reference group. Potential causes of the above findings are discussed.     

滨海沙土微量元素与木麻黄生长的关系

本文探讨了广东滨海沙土中微量元素B、Mo、Mn、Cu、Zn与木麻黄生长的关系,结果表明:B、Mo有利于促进生长与抗病,Cu含量高对生长有抑制作用,其余的作用不明显。     

Evaluation and Treatment of Children with Primary Immune Deficiency in the Emergency Department

The potential for morbidity and mortality in patients who have PID with febrile and nonfebrile illness is extremely high. Familiarity with the clinical manifestations of PID and collaboration with a pediatric immunologist are prerequisites for optimal short-term care of these complex patients. Conservative management with empiric broad-spectrum antimicrobials, early and aggressive surgical debridement of abscesses, and admission at a tertiary pediatric care center are often indicated.     

Metabolic and hormonal blood flow modeling in patients with coronary heart disease: In vitro and clinical study

The blood flow pattern investigations are of great importance in coronary blood flow destabilization pathogenesis understanding, and consequently in acute coronary event (ACE) risk stratification in patients with coronary heart disease. The aim of the study was to research the principal hormonal and metabolic blood flow regulative aspects and its structure in patients with ischemic heart disease and the contribution to cumulative ACE risk.A total of 182 patients with stable angina pectoris were included in the prospective study (2000–2006). Complex clinical examination, biochemical tests and blood tests were performed. Whole-blood (WB) viscosity, erythrocyte aggregation and deformation ability, WB suspension stability, and initial erythrocytes disaggregation parameter were studied. Dynamic characteristics of blood flow were obtained in the experiment.Received results allow marking the principle components of blood flow pattern with proven high prognostic value of ACE in patients with ischemic heart disease. ACE risk stratification program was developed.     

Low–Density Lipoprotein Apheresis Versus Lipid Lowering Drugs in the Treatment of Severe Hypercholesterolemia: Four Years' Experience

Abstract: Elevated lipoprotein concentrations seem to be linked strongly in a dose dependent manner to an increased incidence of atherosclerosis. A total of 47 patients suffering from severe hyperlipidemia were matched to treatment with LDL apheresis (Baxter, Kaneka, Li–popak; 24 patients, aged 50.2 ±11.5 years), diet, and/or lipid–lowering drugs or with diet and lipid–lowering drugs only (23 patients, aged 48.8 ±11.8 years). After treatment periods of 49.8 ±13.4 months (apheresis group, 2,396 treatment sessions) and 38.6 ± 15.1 months (drug group), the ensuing results revealed significant differences (p <0.0001): –47.3% versus –12.1% for total cholesterol, –46.9% versus –21.8% for LDL, +8.4% versus +0.9% for HDL, –52.0% versus – 13.1% for the LDL/HDL ratio, –36.4% versus –16.2% for triglycerides, and –25.9% versus + 1.5% for lipoprotein (a). In the apheresis group, one patient died of myocardial infarction; in the drug group, there was one nonfatal myocardial infarction and the manifestation of coronary heart disease in 3 cases. There were no severe side effects in either group. All patients in the apheresis group responded to therapy. The present trial suggests that a continuing reduction in serum lipid concentrations may lower, in a dose dependent manner, the risk for development and progression of coronary heart disease. Regarding clinical and laboratory results, LDL apheresis seems to be safe, effective therapy for treatment of severe hyperlipidemia.